LRRK2 and Parkinson disease: RT‐QuIC has also been tested in symptomatic and non-symptomatic patients carrying a LRRK2 mutation, a common genetic risk factor for familial and sporadic PD, and seeding propensity was shown in a subset of patients (Garrido et al. 2019).